BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31313299)

  • 1. Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile.
    Hofvander J; Puls F; Pillay N; Steele CD; Flanagan AM; Magnusson L; Nilsson J; Mertens F
    J Pathol; 2019 Dec; 249(4):425-434. PubMed ID: 31313299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma.
    Hofvander J; Tayebwa J; Nilsson J; Magnusson L; Brosjö O; Larsson O; Vult von Steyern F; Mandahl N; Fletcher CD; Mertens F
    Clin Cancer Res; 2015 Feb; 21(4):864-9. PubMed ID: 25516889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
    Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
    J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 Cases.
    Puls F; Pillay N; Fagman H; Palin-Masreliez A; Amary F; Hansson M; Kindblom LG; McCulloch TA; Meligonis G; Muc R; Rissler P; Sumathi VP; Tirabosco R; Hofvander J; Magnusson L; Nilsson J; Flanagan AM; Mertens F
    Am J Surg Pathol; 2019 Apr; 43(4):504-513. PubMed ID: 30570551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analyses of undifferentiated small round cell sarcoma identifies a novel sarcoma subtype with a recurrent CRTC1-SS18 gene fusion.
    Alholle A; Karanian M; Brini AT; Morris MR; Kannappan V; Niada S; Niblett A; Ranchère-Vince D; Pissaloux D; Delfour C; Maran-Gonzalez A; Antonescu CR; Sumathi V; Tirode F; Latif F
    J Pathol; 2018 Jun; 245(2):186-196. PubMed ID: 29533464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.
    Puls F; Carter JM; Pillay N; McCulloch TA; Sumathi VP; Rissler P; Fagman H; Hansson M; Amary F; Tirabosco R; Magnusson L; Nilsson J; Flanagan AM; Folpe AL; Mertens F
    Mod Pathol; 2022 Jun; 35(6):767-776. PubMed ID: 34969957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
    Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
    Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical positive regulatory domain member 10 expression in soft tissue sarcomas.
    Mistik O; Sayar H
    Pol J Pathol; 2022; 73(3):223-232. PubMed ID: 36734437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent PRDM10 Fusions in Superficial CD34-Positive Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 10 Additional Cases of an Emerging Novel Entity.
    Zhao M; Yin X; He H; Fan Y; Ru G; Meng X
    Am J Clin Pathol; 2023 Apr; 159(4):367-378. PubMed ID: 36812381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel ATXN1/ATXN1L::NUTM2A fusions identified in aggressive infant sarcomas with gene expression and methylation patterns similar to CIC-rearranged sarcoma.
    Xu F; Viaene AN; Ruiz J; Schubert J; Wu J; Chen J; Cao K; Fu W; Bagatell R; Fan Z; Long A; Pagliaroli L; Zhong Y; Luo M; Kreiger PA; Surrey LF; Wertheim GB; Cole KA; Li MM; Santi M; Storm PB
    Acta Neuropathol Commun; 2022 Jul; 10(1):102. PubMed ID: 35836290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undifferentiated pleomorphic sarcoma with co-existence of KRAS/PIK3CA mutations.
    Li B; Li L; Li X; Wang Y; Xie Y; Liu C; Li F
    Int J Clin Exp Pathol; 2015; 8(7):8563-7. PubMed ID: 26339434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superficial CD34 fibroblastic tumors and PRDM10-rearranged soft tissue neoplasm: An evolving diagnosis.
    Johnson C; Parsa L; Gibbs J; Sligh J
    J Cutan Pathol; 2024 Jan; 51(1):11-14. PubMed ID: 37150806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
    Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
    Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors.
    Dickson BC; Sung YS; Rosenblum MK; Reuter VE; Harb M; Wunder JS; Swanson D; Antonescu CR
    Am J Surg Pathol; 2018 May; 42(5):636-645. PubMed ID: 29356724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
    Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
    Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children.
    Peters TL; Kumar V; Polikepahad S; Lin FY; Sarabia SF; Liang Y; Wang WL; Lazar AJ; Doddapaneni H; Chao H; Muzny DM; Wheeler DA; Okcu MF; Plon SE; Hicks MJ; López-Terrada D; Parsons DW; Roy A
    Mod Pathol; 2015 Apr; 28(4):575-86. PubMed ID: 25360585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma.
    Motoi T; Hirata M; Kukita Y; Satomi K; Tamura H; Adachi S; Matsushita Y; Horiguchi SI; Hishima T; Ikegami M; Okuma T; Tao K; Arakawa A; Ogawa C; Matsuda K; Ichimura K; Nakamura H; Mori T; Yoshida A
    Mod Pathol; 2023 Nov; 36(11):100317. PubMed ID: 37634866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern.
    Haller F; Knopf J; Ackermann A; Bieg M; Kleinheinz K; Schlesner M; Moskalev EA; Will R; Satir AA; Abdelmagid IE; Giedl J; Carbon R; Rompel O; Hartmann A; Wiemann S; Metzler M; Agaimy A
    J Pathol; 2016 Apr; 238(5):700-10. PubMed ID: 26863915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
    Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
    Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficial CD34-Positive Fibroblastic Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Study of 59 Cases.
    Anderson WJ; Mertens F; Mariño-Enríquez A; Hornick JL; Fletcher CDM
    Am J Surg Pathol; 2022 Oct; 46(10):1329-1339. PubMed ID: 35713642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.